Latest News: Treatments & Research

Positive Interim Results from Phase I Trial Announced by Scholar Rock

18 March 2019 / Posted in: Treatments & Research

Scholar Rock have announced positive interim results from an ongoing Phase I trial in healthy volunteers of their lead compound, SRK-015.

Read full story

Family Attitudes to Genome Editing for Prevention of Heritable Disorders

08 March 2019 / Posted in: Treatments & Research

This study involves an online survey for people aged 18 or over who either have a genetic condition themselves, or have someone in their family who has / had a genetic condition. It's being led by University College London with a closing date of 30th May.

Read full story

Rare Diseases: Open Letter to the UK Government

08 March 2019 / Posted in: Treatments & Research

Over 125 patient organisations, including SMA UK, have signed an open letter calling on the UK Government to review and refresh, as a matter of urgency, the UK Strategy for Rare Diseases before the end of 2020.

Read full story

The Financial and Work-Related Impact of Living with SMA Type 1, 2 or 3 for Unpaid Carers

05 March 2019 / Posted in: Treatments & Research

Thank you to all who responded to this survey, and to Wickenstones for their analysis. The results and the results of our survey last year about the impact of SMA are now available and are being used to inform Biogen’s continuing work with NICE re: access to nusinersen. Read the results summary here.

Read full story

Letter Written By Clinicians Highlights Frustrations Around Spinraza Access

04 March 2019 / Posted in: Treatments & Research

The letter, published in The Guardian, highlights the clinicians’ frustrations at Spinraza not being made available on the NHS in England, Wales and Northern Ireland.

Read full story

SMA UK Calling for Urgent Access to Nusinersen

04 March 2019 / Posted in: Treatments & Research

On Wednesday 6th March, we will be at NICE’s third committee meeting working hard to express the urgent need for a positive recommendation.

Read full story

'Time is Running Out' - Please send this powerful handout and template letter to your MP today

26 February 2019 / Posted in: Treatments & Research

A huge thank you to all who personally gave copies of these and spoke about their lives to MPs at yesterday's Access to nusinersen parliamentary drop-in session. You can contact your MP, asking them to use these to write to NICE, Biogen and NHS England

Read full story

Your help needed to find health professionals to take part in study into costs and treatment of SMA

22 February 2019 / Posted in: Treatments & Research

A biotechnology company is investigating a new treatment for SMA and wants to arrange interviews with health visitors, community nurses, physios, OTs, nurses in neurology wards, nutritionists, neurologists and pulmonologists who have seen a minimum of 2 patients with SMA Type 1, 2 or 3 in the last 12 months. Please pass this request on to the health professionals who support you to see if they wish to get involved.

Read full story

SMA UK Activity During the Week of Rare Disease Day

22 February 2019 / Posted in: Treatments & Research

Monday, we’re at the Parliamentary 'drop-in' session about access to nusinersen; Tuesday, our Scientific Research Correspondent will be attending Royal Holloway’s Rare Disease Day event; on Rare Disease Day itself, we’ll be at a Cambridge Lecture evening about research and have a a notice in the Guardian Rare Diseases supplement.

Read full story

UK SMA Research Day 2019

21 February 2019 / Posted in: Treatments & Research

Hosted at Keele University in Keele Hall, the latest UK SMA researcher meeting was organised and chaired by Dr. Melissa Bowerman on Wednesday 23rd January 2019. Scientists of all career stages representing many UK research institutions were in attendance for a full day of excellent presentations on SMA. Read this summary by our Scientific Research Correspondent, Dr James Sleigh.

Read full story